Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

An Adaptive Parent-mediated Intervention to Improve Outcomes for Autistic Children

12 de noviembre de 2026 actualizado por: Florida International University

High quality early intervention offers significant benefits for autistic children, yet most programs fail to adjust the level of support needed to sustain parent engagement and maximize efficacy. We will utilize a Sequential Multiple Assignment Randomized Trial (SMART) trial, an implementation research design in which participants are re-randomized at key decision points, to explore methods to improve engagement in OPT-In-Early (Online Parent Training in Early Behavioral Intervention). OPT-In-Early is a self-directed online autism parent-training program that teaches evidence-based behavioral/developmental strategies to promote child skill development and reduce interfering behaviors. In this adaptive intervention, parents will first be randomized to either OPT-In-Early or OPT-In-Early with automated support. We will monitor progress and intervene early (during Month 1 of the 6-month intervention) to identify parents who either (1) demonstrate low engagement with the program or (2) use the program but do not learn information. These parents needing extra support will then be re-randomized to receive additional remote clinical support, either in the form of group or individual intervention. The intervention will be based on OPT-In-Early principles. An adaptive approach to OPT-In-Early may improve child outcomes while using resources more judiciously.

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Tipo de estudio

Intervencionista

Inscripción (Estimado)

680

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Yael Dai, PhD
  • Número de teléfono: 305-348-1034
  • Correo electrónico: ydai@fiu.edu

Copia de seguridad de contactos de estudio

  • Nombre: Katharine Zuckerman, MD, MPH
  • Número de teléfono: 503-418-5700
  • Correo electrónico: zuckerma@ohsu.edu

Ubicaciones de estudio

    • Florida
      • Miami, Florida, Estados Unidos, 33199
        • Florida International University
        • Contacto:
          • Yael Dai, PhD
          • Número de teléfono: 3053481034
          • Correo electrónico: ydai@fiu.edu
        • Contacto:
        • Investigador principal:
          • Yael Dai, PhD
      • Miami, Florida, Estados Unidos, 33146
        • University of Miami
        • Contacto:
    • Oregon
      • Portland, Oregon, Estados Unidos, 97239
        • Oregon Health & Science University
        • Contacto:
          • Katharine Zuckerman, MD, MPH
          • Número de teléfono: 503-418-5700
          • Correo electrónico: zuckerma@ohsu.edu

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

1 año y mayores (Niño, Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Child age 14 to 48 months with a medical diagnosis and/or educational label of autism
  • Caregiver (a) 18 years or older, (b) fluent in English or Spanish, (c) has physical custody of the child (at least 50% of the time)

Exclusion Criteria:

  • Child (a) has severe hearing and/or vision impairment that is uncorrected with aids, (b) is not yet walking, (c) is receiving more than 20 hours of intervention per week at baseline
  • Caregiver is receiving weekly autism-related parent coaching

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación Secuencial
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: OPT-In-Early

This group will receive access to OPT-In-Early. OPT-In-Early is an online 14-module self-directed parent-training program that uses simple text, narration, and interspersed videos to teach parents how to increase their children's social engagement, communication, adaptive behaviors, and reduce challenging behaviors.

This study will test an adaptive version of OPT-In-Early, in which low-engaged participants will be re-randomized to receive either individual or group support to supplement their review of OPT-In-Early.

Experimental: OPT-In-Early + Automated Support

Participants will access the OPT-In-Early website, and their review will be supplemented with weekly automated text messages that send parents reminders and encouragement.

This study will test an adaptive version of OPT-In-Early, in which low-engaged participants will be re-randomized to receive either individual or group support to supplement their review of OPT-In-Early.

Experimental: OPT-In-Early + Individual Professional Support

This group will include participants who were initially assigned to the OPT-In-Early group, but were then classified as having "low engagement" and were re-randomized to OPT-In-Early + Individual Professional Support after Month 1 of the study. Following re-randomization (months 2-6), these participants will be asked to continue to review OPT-In-Early on their own, but they will also be invited to participate in weekly individual virtual professional support meetings.

This study will test an adaptive version of OPT-In-Early, in which low-engaged participants will be re-randomized to receive either individual or group support to supplement their review of OPT-In-Early.

Experimental: OPT-In-Early + Automated Support + Individual Professional Support

Participants in this group will include parents who were initially assigned to the OPT-In-Early + Automated Support condition, but were classified as having "low engagement" and were then re-randomized to OPT-In-Early + Automated support+ Individual Professional Support after Month 1. Following re-randomization, these participants will be asked to continue to review OPT-In-Early independently, but they will also invited to participate in virtual weekly individual professional support meetings.

This study will test an adaptive version of OPT-In-Early, in which low-engaged participants will be re-randomized to receive either individual or group support to supplement their review of OPT-In-Early.

Experimental: OPT-In-Early + Group Professional Support

The OPT-In-Early + Group Professional Support will include participants who were initially assigned to the OPT-In-Early group, but were then classified as having "low engagement" and were re-randomized to OPT-In-Early + Group Professional Support after Month 1. Following re-randomization, these participants will be asked to continue to review OPT-In-Early independently, but they will also invited to participate in virtual group support meetings.

This study will test an adaptive version of OPT-In-Early, in which low-engaged participants will be re-randomized to receive either individual or group support to supplement their review of OPT-In-Early.

Experimental: OPT-In-Early + Automated Support + Group Professional Support

The OPT-In-Early + Automated Support + Group Support will include participants who were initially assigned to the OPT-In-Early + automated support group but were then but were then classified as having "low engagement" and were re-randomized to OPT-In-Early + Automated support + Group Professional Support after Month 1. Following re-randomization, these participants will be asked to continue to review OPT-In-Early independently, but they will also invited to participate in weekly virtual group support meetings.

This study will test an adaptive version of OPT-In-Early, in which low-engaged participants will be re-randomized to receive either individual or group support to supplement their review of OPT-In-Early.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Autism Impact Measure
Periodo de tiempo: Baseline to Follow-up (12 Months)

The AIM is one of few measures designed specifically to assess behavioral change in autistic individuals that results form interventions, and it is sensitive to change over short-term treatment. For each behavior or developmental milestone listed, the parent indicates the frequency of the behavior and the impact that the parent thinks it has on the child's everyday functioning. Western Psychological Services (the publisher) has translated this instrument to Spanish.

Baseline to Follow-up (12 Months)
MacArthur-Bates Communicative Development Inventories
Periodo de tiempo: Baseline and Follow-up (12 Months)

The MacArthur-Bates Communication Development Inventory (MCDI) is a parent-report measure that assesses child verbal and nonverbal communication. The MCDI is widely used, standardized, and validated. It is particularly well-suited for large-scale research due to ease of administration, strong psychometric properties, and sensitivity to individual differences in early language development. Higher scores indicate greater communication.

Baseline and Follow-up (12 Months)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Motor Imitation Scale
Periodo de tiempo: Baseline and Follow-up (12 Months)

The Motor Imitation Scale is a standardized, structured observational measure that assesses a child's ability to imitate familiar and novel motor actions. Children will see actions modeled and then will be prompted to imitate the action using a matching toy. Children are given up to three opportunities to imitate each action. Higher scores indicating greater imitation. The precedent has been established for successfully using this measure during remote parent-mediated assessments. We have received permission from the author of the MIS to use an abbreviated 8-item version of this measure.

Baseline and Follow-up (12 Months)
Vineland Scales of Adaptive Behavior- Third Edition
Periodo de tiempo: Baseline and Follow-up (12 months)

The Vineland-3 is a standardized parent interview that measures children's adaptive functioning. It will be administered to all participants at baseline and follow-up to evaluate change occurring in adaptive behavior across groups. The Previous research has shown that the Vineland has robust psychometric properties, is sensitive to change in response to early intervention, and captures dimensions that are highly valued by autistic individuals and their parents. Higher scores in the Vineland indicate more advanced adaptive skills.

Baseline and Follow-up (12 months)

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Opt-In-Early Knowledge Check
Periodo de tiempo: Baseline and Post-treatment (6 Months)

The study investigators created a multiple-choice quiz to assess knowledge of the content covered in the first six (core) modules of OPT-In-Early. The quiz was created without using the module content verbatim and therefore requires the ability to understand and apply the principles taught.

Baseline and Post-treatment (6 Months)
Social Interaction Rating Scale (SIRS)
Periodo de tiempo: Baseline and Post-treatment (6 Months)

The SIRS is a measure of observed parent use of intervention strategies, to assess Parent Fidelity. This observational measure is videotaped and coded by a trained rater masked to group and time. Parents are asked to do 4 activities with their child, keeping the child as engaged as possible: (1) Work on a puzzle (2) Teach their child to imitate them doing a simple behavior that they haven't already taught them to imitate; (3) Play with their child using bubbles. (4) Feed their child a snack. Each activity is recorded for 3 minutes. Parents' responsivity to the child based on behavioral and affective principles emphasized throughout OPT-In- Early are coded: positive affect, contingent reinforcement, appropriate directiveness, promotion of eye contact, and appropriate level of prompting. Each item is scored on a 5-point Likert scale Scores on the 5 items are also summed to yield a total score. This measure may be administered in-person or remotely via videoconference.

Baseline and Post-treatment (6 Months)
Autism Parenting Stress Index (APSI)
Periodo de tiempo: Baseline and Post-treatment (6 Months)

The APSI is a 13-item parent-report questionnaire that captures unique stressors associated with parenting an autistic child. It is intended to assess the effect of intervention on parenting stress. Many items correspond to topics covered in OPT-In-Early (e.g.,child's communication, disruptive behavior, feeding, toilet training). The APSI has strong psychometric properties and has been translated to Spanish.

Baseline and Post-treatment (6 Months)
Tailoring Variable
Periodo de tiempo: First month of the study

To determine whether participants are classified as "engaged" or having "low engagement," two metrics will be used: usage analytics and knowledge attainment. Both are measured one month after study enrollment. Usage analytics on the OPT-In-Early website will be tracked. Participants will receive a unique username and password to access OPT-In-Early. This will enable the study team to monitor participants' activity on OPT-In-Early, including module completion and module quiz score. Parents must complete at least two core OPT-In-Early modules in the first month of program access to be classified as "engaged." Additionally, OPT-In-Early knowledge attainment will be measured using the Post-Module Knowledge Check following modules 1 and 2. The quizzes will contain pre-tested multiple-choice questions about the most pertinent information covered. Parents must score ≥ 80% on these cumulative questions to be classified as "engaged."

First month of the study

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Yael Dai, PhD, Florida International University

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de enero de 2027

Finalización primaria (Estimado)

1 de enero de 2031

Finalización del estudio (Estimado)

1 de enero de 2031

Fechas de registro del estudio

Enviado por primera vez

12 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

12 de noviembre de 2026

Publicado por primera vez (Actual)

18 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

18 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

12 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 117053
  • 1R01MH144636-01 (Subvención/contrato del NIH de EE. UU.)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Descripción del plan IPD

We will be submitting data to NIMH NDA archive as required by the funder

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir